UNSPSC 41105517: Kits for nucleic acid extraction from plant cells or tissue

UNSPSC 41105517 Kits for nucleic acid extraction from plant cells or tissue is a Commodity code that in practice captures DNA extraction reagents, kits, and related consumables used by state and local forensic laboratories, public health agencies, and specialized research facilities for human DNA analysis, newborn screening, and diagnostic PCR work—a notably different scope from the botanical framing the code's abstract name suggests. State and local buyers under this code include forensic laboratories (Texas Department of Public Safety Crime Lab, Mississippi Forensic Laboratory, Illinois State Police), health and human services agencies (Texas Health and Human Services Commission and Department of State Health Services), and specialized public health programs such as newborn screening. Recent solicitations show state forensic labs and public health departments procuring branded reagent kits and consumables tied to specific instrument platforms—RapidHIT cartridges and sample kits for human DNA identification and fragment analysis, QuantaBio extraction reagents for SCID and SMA screening, Life Technologies kits and capillaries, and Promega PowerPlex STR amplification kits for DNA casework indexing.

Texas dominates recent activity, with the Texas Department of Public Safety Crime Lab, Texas Health and Human Services Commission, and Texas DSHS issuing multiple IFBs for DNA consumables (posted July 7, 2026, due July 22, 2026), extraction reagents for newborn screening (posted July 1, 2026, due July 15, 2026), and digital PCR instruments with DNA extractors (IFB HHS0016959v2, due May 14, 2026). Mississippi and Illinois round out the active jurisdictions, with the Mississippi Forensic Laboratory issuing an RFI for Life Technologies products (posted June 30, 2026, due July 21, 2026) and the Illinois State Police soliciting a nine-year IFB for Promega PowerPlex kits and reagents (posted February 6, 2026, due February 20, 2026). The Texas HHSC procurement for DNA extraction reagents for newborn screening notes historical spend of $2.5 million for the September 2025 through November 2025 period, suggesting material contract values in active jurisdictions. All recent solicitations specify proprietary or sole-source products—RapidHIT, QuantaBio, Life Technologies, Promega, or QIAGEN—which structurally narrows competition to authorized distributors or resellers of those manufacturers' lines.